The current study seeks to better characterize the repertoire and stoichiometry of albumin citrullination sites in RA by mass spectrometry and to assess ACPA reactivity at each site compared with healthy control (HC) and systemic lupus erythematosus patients as a disease control. This evidence concerns the gene ALB and rheumatoid arthritis.